What is the appropriate treatment for viral labyrinthitis?

Treatment of Viral Labyrinthitis

Viral labyrinthitis is primarily managed with supportive care and symptomatic treatment, as there is no proven benefit from antiviral therapy, and corticosteroids have limited evidence for routine use. 1

Symptomatic Management

Vestibular Suppressants (Short-Term Only)

• Do not routinely prescribe vestibular suppressants such as antihistamines (meclizine, diphenhydramine) or benzodiazepines (diazepam, clonazepam) beyond the acute phase 2
• These medications may provide short-term relief of severe vertigo and nausea during the initial 24-48 hours 2
• Prolonged use interferes with central vestibular compensation and should be avoided 2
• Antihistamines primarily suppress the central emetic center to reduce nausea and vomiting, while benzodiazepines reduce the subjective sensation of spinning but impair recovery 2

Antiemetics

• Antiemetics such as promethazine or ondansetron can be used for severe nausea and vomiting during the acute phase 2
• These should be discontinued as soon as tolerated to allow vestibular compensation 2

Antiviral Therapy: Not Recommended

Do not prescribe antiviral medications for viral labyrinthitis 3, 1

• Multiple randomized controlled trials have failed to demonstrate benefit from antiviral therapy in sudden sensorineural hearing loss and vestibular disorders 3, 4
• A prospective, randomized, double-blind trial of acyclovir combined with prednisolone showed no beneficial effect on hearing recovery in patients with sudden hearing loss and vestibular symptoms 4
• Recent evidence in sudden sensorineural hearing loss has resulted in recommendations against viral serology or the use of antivirals 1
• Antiviral agents carry side effects including nausea, vomiting, photosensitivity, and rarely reversible neurologic reactions 3

Corticosteroid Therapy: Limited Evidence

The role of corticosteroids in viral labyrinthitis remains controversial and is not routinely recommended 5, 1

• There is presently not sufficient evidence to support the routine use of corticosteroids in acute vestibular disorders 1
• Corticosteroids may theoretically reduce inflammation but could also facilitate viral replication 5
• If considering corticosteroids in severe cases with marked hearing loss, a short course (e.g., prednisolone 60-80 mg daily for 3-5 days) may be used under specialist supervision 5
• This decision should be made on a case-by-case basis, recognizing the lack of strong supporting evidence 5

Vestibular Rehabilitation

Vestibular rehabilitation should be initiated once the acute phase subsides 2, 6

• Early mobilization and vestibular exercises promote central compensation 2
• Rehabilitation can be self-administered or supervised by a trained therapist 6
• Patients should be encouraged to resume normal activities as tolerated, as prolonged bed rest delays recovery 2

Prognosis and Follow-Up

• Vertigo typically lasts 12-36 hours with gradual improvement, though residual disequilibrium may persist for 4-5 days 7
• Hearing loss in labyrinthitis is typically permanent and non-fluctuating, unlike Ménière's disease 7
• Only 20% of patients experience subjective hearing recovery 8
• 72.5% of patients continue to experience balance problems at long-term follow-up (median 61 months) 8
• Reassess patients within 1 month to document symptom resolution or persistence 6

Key Differentiating Features

Labyrinthitis presents with:

• Sudden severe rotatory vertigo lasting >24 hours (not episodic) 7
• Concurrent profound sensorineural hearing loss at vertigo onset 7
• Symptoms are not triggered by head position (distinguishing it from BPPV) 7
• Hearing loss is non-fluctuating (unlike Ménière's disease, which has episodes lasting 20 minutes to 12 hours) 7

The presence of hearing loss distinguishes labyrinthitis from vestibular neuritis, which presents with severe vertigo without hearing loss, tinnitus, or aural fullness 7

Common Pitfalls to Avoid

• Do not prescribe prolonged vestibular suppressants, as they delay central compensation 2
• Do not routinely order antiviral therapy, as multiple trials show no benefit 3, 1, 4
• Do not assume hearing will recover—counsel patients that hearing loss is typically permanent 7, 8
• Do not overlook the need for vestibular rehabilitation, which is essential for functional recovery 2, 6
• Ensure patients understand the high likelihood of persistent balance problems requiring long-term adaptation strategies 8